BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maheshwari A, Fischer M, Gambetti P, Parker A, Ram A, Soto C, Concha-Marambio L, Cohen Y, Belay ED, Maddox RA, Mead S, Goodman C, Kass JS, Schonberger LB, Hussein HM. Recent US Case of Variant Creutzfeldt-Jakob Disease-Global Implications. Emerg Infect Dis 2015;21:750-9. [PMID: 25897712 DOI: 10.3201/eid2105.142017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Ritchie DL, Peden AH, Barria MA. Variant CJD: Reflections a Quarter of a Century on. Pathogens 2021;10:1413. [PMID: 34832569 DOI: 10.3390/pathogens10111413] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Wang Z, Qin K, Camacho MV, Cali I, Yuan J, Shen P, Greenlee J, Kong Q, Mastrianni JA, Zou WQ. Generation of human chronic wasting disease in transgenic mice. Acta Neuropathol Commun 2021;9:158. [PMID: 34565488 DOI: 10.1186/s40478-021-01262-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
3 Watson N, Brandel JP, Green A, Hermann P, Ladogana A, Lindsay T, Mackenzie J, Pocchiari M, Smith C, Zerr I, Pal S. The importance of ongoing international surveillance for Creutzfeldt-Jakob disease. Nat Rev Neurol 2021;17:362-79. [PMID: 33972773 DOI: 10.1038/s41582-021-00488-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
4 Sheshe SM. Creutzfeldt-Jakob Disease. Research Anthology on Diagnosing and Treating Neurocognitive Disorders 2021. [DOI: 10.4018/978-1-7998-3441-0.ch003] [Reference Citation Analysis]
5 Patniyot NS, Patniyot IR. Variant Creutzfeldt-Jakob Disease Presenting as New-onset Psychosis. J Psychiatr Pract 2019;25:58-62. [PMID: 30633734 DOI: 10.1097/PRA.0000000000000352] [Reference Citation Analysis]
6 Bošnjak M, Zupan A, Fiorini M, Popović KŠ, Popović M. A case of MV2K subtype of sporadic Creutzfeldt-Jakob disease with florid-like plaques: Similarities and differences to variant Creutzfeldt-Jakob disease. Neuropathology 2020;40:389-98. [PMID: 32249464 DOI: 10.1111/neup.12652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Tee BL, Longoria Ibarrola EM, Geschwind MD. Prion Diseases. Neurol Clin 2018;36:865-97. [PMID: 30366560 DOI: 10.1016/j.ncl.2018.07.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
8 Sheshe SM. Creutzfeldt-Jakob Disease. Advances in Medical Diagnosis, Treatment, and Care 2019. [DOI: 10.4018/978-1-5225-5282-6.ch017] [Reference Citation Analysis]
9 Hwang S, Greenlee JJ, Vance NM, Nicholson EM. Source genotype influence on cross species transmission of transmissible spongiform encephalopathies evaluated by RT-QuIC. PLoS One 2018;13:e0209106. [PMID: 30571737 DOI: 10.1371/journal.pone.0209106] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
10 Coulthart MB, Geschwind MD, Qureshi S, Phielipp N, Demarsh A, Abrams JY, Belay E, Gambetti P, Jansen GH, Lang AE, Schonberger LB. A case cluster of variant Creutzfeldt-Jakob disease linked to the Kingdom of Saudi Arabia. Brain 2016;139:2609-16. [PMID: 27671029 DOI: 10.1093/brain/aww206] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
11 Sevillano AM, Fernández-Borges N, Younas N, Wang F, R Elezgarai S, Bravo S, Vázquez-Fernández E, Rosa I, Eraña H, Gil D, Veiga S, Vidal E, Erickson-Beltran ML, Guitián E, Silva CJ, Nonno R, Ma J, Castilla J, R Requena J. Recombinant PrPSc shares structural features with brain-derived PrPSc: Insights from limited proteolysis. PLoS Pathog 2018;14:e1006797. [PMID: 29385212 DOI: 10.1371/journal.ppat.1006797] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
12 Brandel JP, Knight R. Variant Creutzfeldt-Jakob disease. Handb Clin Neurol 2018;153:191-205. [PMID: 29887136 DOI: 10.1016/B978-0-444-63945-5.00011-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
13 Concha-Marambio L, Pritzkow S, Moda F, Tagliavini F, Ironside JW, Schulz PE, Soto C. Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease. Sci Transl Med 2016;8:370ra183. [PMID: 28003548 DOI: 10.1126/scitranslmed.aaf6188] [Cited by in Crossref: 102] [Cited by in F6Publishing: 104] [Article Influence: 17.0] [Reference Citation Analysis]
14 Wall BA, Arnold ME, Radia D, Gilbert W, Ortiz-Pelaez A, Stärk KD, Van Klink E, Guitian J. Evidence for more cost-effective surveillance options for bovine spongiform encephalopathy (BSE) and scrapie in Great Britain. Euro Surveill 2017;22:30594. [PMID: 28816650 DOI: 10.2807/1560-7917.ES.2017.22.32.30594] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
15 Yang Q, Zhang S, Liu L, Cao X, Lei C, Qi X, Lin F, Qu W, Qi X, Liu J, Wang R, Chen H, Lan X. Application of mathematical expectation (ME) strategy for detecting low frequency mutations: An example for evaluating 14-bp insertion/deletion (indel) within the bovine PRNP gene. Prion 2016;10:409-19. [PMID: 27580010 DOI: 10.1080/19336896.2016.1211593] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 7.8] [Reference Citation Analysis]
16 Yang H, Huang Y, Gregori L, Asher DM, Bui T, Forshee RA, Anderson SA. Geographic exposure risk of variant Creutzfeldt-Jakob disease in US blood donors: a risk-ranking model to evaluate alternative donor-deferral policies: GEOGRAPHIC vCJD RISK. EDITORIAL 2017;57:924-32. [DOI: 10.1111/trf.13971] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
17 Logue CM, Barbieri NL, Nielsen DW. Pathogens of Food Animals: Sources, Characteristics, Human Risk, and Methods of Detection. Adv Food Nutr Res 2017;82:277-365. [PMID: 28427535 DOI: 10.1016/bs.afnr.2016.12.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
18 Kong Q, Bessen RA. Prion Diseases. Neuroimmune Pharmacology 2017. [DOI: 10.1007/978-3-319-44022-4_34] [Reference Citation Analysis]
19 Vázquez-Fernández E, Young HS, Requena JR, Wille H. The Structure of Mammalian Prions and Their Aggregates. Int Rev Cell Mol Biol 2017;329:277-301. [PMID: 28109330 DOI: 10.1016/bs.ircmb.2016.08.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
20 Paz SA, Vanden-Eijnden E, Abrams CF. Polymorphism at 129 dictates metastable conformations of the human prion protein N-terminal β-sheet. Chem Sci 2017;8:1225-32. [PMID: 28451263 DOI: 10.1039/c6sc03275c] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
21 Brandt AL, Kelly AC, Green ML, Shelton P, Novakofski J, Mateus-Pinilla NE. Prion protein gene sequence and chronic wasting disease susceptibility in white-tailed deer (Odocoileus virginianus). Prion 2015;9:449-62. [PMID: 26634768 DOI: 10.1080/19336896.2015.1115179] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
22 Geschwind MD. Prion Diseases. Continuum (Minneap Minn) 2015;21:1612-38. [PMID: 26633779 DOI: 10.1212/CON.0000000000000251] [Cited by in Crossref: 61] [Cited by in F6Publishing: 84] [Article Influence: 8.7] [Reference Citation Analysis]
23 Urayama A, Concha-Marambio L, Khan U, Bravo-Alegria J, Kharat V, Soto C. Prions efficiently cross the intestinal barrier after oral administration: Study of the bioavailability, and cellular and tissue distribution in vivo. Sci Rep 2016;6:32338. [PMID: 27573341 DOI: 10.1038/srep32338] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
24 Geschwind MD, Lanata S. Jakob–Creutzfeldt disease and other prion diseases. The Behavioral Neurology of Dementia 2016. [DOI: 10.1017/9781139924771.022] [Reference Citation Analysis]
25 Requena JR, Kristensson K, Korth C, Zurzolo C, Simmons M, Aguilar-Calvo P, Aguzzi A, Andreoletti O, Benestad SL, Böhm R, Brown K, Calgua B, Del Río JA, Espinosa JC, Girones R, Godsave S, Hoelzle LE, Knittler MR, Kuhn F, Legname G, Laeven P, Mabbott N, Mitrova E, Müller-Schiffmann A, Nuvolone M, Peters PJ, Raeber A, Roth K, Schmitz M, Schroeder B, Sonati T, Stitz L, Taraboulos A, Torres JM, Yan ZX, Zerr I. The Priority position paper: Protecting Europe's food chain from prions. Prion 2016;10:165-81. [PMID: 27220820 DOI: 10.1080/19336896.2016.1175801] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
26 Kim Y, Rodriguez AE, Nowzari H. The Risk of Prion Infection through Bovine Grafting Materials. Clin Implant Dent Relat Res 2016;18:1095-102. [PMID: 26856530 DOI: 10.1111/cid.12391] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
27 Zhang B, Zhu D, Wang W, Gong G, Du W. Influence of oxodiperoxovanadate complexes on prion neuropeptide fibril formation. RSC Adv 2016;6:17083-91. [DOI: 10.1039/c5ra25849a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
28 Manix M, Kalakoti P, Henry M, Thakur J, Menger R, Guthikonda B, Nanda A. Creutzfeldt-Jakob disease: updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy. FOC 2015;39:E2. [DOI: 10.3171/2015.8.focus15328] [Cited by in Crossref: 91] [Cited by in F6Publishing: 99] [Article Influence: 11.4] [Reference Citation Analysis]